Serum vitamin D levels among patients in a clinical oncology practice compared to primary care patients in the same community: a case-control study

被引:8
作者
Churilla, Thomas M. [1 ]
Lesko, Samuel L. [1 ,2 ]
Brereton, Harmar D. [1 ,3 ]
Klem, Mary [3 ]
Donnelly, Patrick E. [4 ]
Peters, Christopher A. [1 ,3 ]
机构
[1] Commonwealth Med Coll, Scranton, PA USA
[2] NE Reg Canc Inst, Scranton, PA USA
[3] NE Radiat Oncol Ctr, Dunmore, PA USA
[4] Princeton Univ, Dept Chem, Frick Lab, Princeton, NJ 08544 USA
关键词
D O I
10.1136/bmjopen-2011-000397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Low serum vitamin D levels have been associated with risk for certain malignancies, but studies have not directly analysed levels between community oncology and primary care practices. The purpose of this study was to compare serum vitamin D levels in patients at a community oncology practice with non-cancer patients at a primary care practice. Design: Retrospective case-control study. 25-Hydroxyvitamin D levels were ordered for screening in both cancer and non-cancer patients. Levels were compared in univariate and multivariate analyses adjusted for age, body mass index and season of blood draw. Setting: A community-based radiation oncology centre and a community-based primary care practice: both located in Northeastern Pennsylvania, USA. Participants: 170 newly diagnosed cancer patients referred for initial consultation at the community oncology centre from 21 November 2008 to 18 May 2010, and 170 non-cancer patients of the primary care practice who underwent screening for hypovitaminosis D for the first time from 1 January 2009 to 31 December 2009. Primary and secondary outcome measures: The primary outcome measure was mean serum vitamin D level, and the secondary outcome measures were frequencies of patients with vitamin D levels <20 ng/ml and levels <30 ng/ml. Results: The oncology patients had a significantly lower mean serum vitamin D level (24.9 ng/ml) relative to a cohort of non-cancer primary care patients (30.6 ng/ml, p<0.001) from the same geographical region. The relationship retained significance after adjustment for age, body mass index and season of blood draw in multivariate analysis (p=0.001). Levels <20 and <30 ng/ml were more frequent in the oncology patients (OR (95% CI)=2.59 (1.44 to 4.67) and 2.04 (1.20 to 3.46), respectively) in multivariate analysis. Conclusions: Cancer patients were found to have low vitamin D levels relative to a similar cohort of non-cancer primary care patients from the same geographical region.
引用
收藏
页数:4
相关论文
共 23 条
[1]   Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) [J].
Ahonen, MH ;
Tenkanen, L ;
Teppo, L ;
Hakama, M ;
Tuohimaa, P .
CANCER CAUSES & CONTROL, 2000, 11 (09) :847-852
[2]  
[Anonymous], 2011, DIETARY REFERENCE IN
[3]   Nonclassic Actions of Vitamin D [J].
Bikle, Daniel .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) :26-34
[4]   Vitamin D and cancer: current dilemmas and future research needs [J].
Davis, Cindy D. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 88 (02) :565S-569S
[5]   Estimates of optimal vitamin D status [J].
Dawson-Hughes, B ;
Heaney, RP ;
Holick, MF ;
Lips, P ;
Meunier, PJ ;
Vieth, R .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (07) :713-716
[6]  
Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502
[7]   Do sunlight and vitamin D reduce the likelihood of colon cancer? (Reprinted from Int J Epidemiol, vol 9, pg 227-31, 1980) [J].
Garland, CF ;
Garland, FC .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (02) :217-220
[8]   The epidemiology of vitamin D and cancer incidence and mortality: A review (United States) [J].
Giovannucci, E .
CANCER CAUSES & CONTROL, 2005, 16 (02) :83-95
[9]  
Giovannucci E, 2008, ADV EXP MED BIOL, V624, P31, DOI 10.1007/978-0-387-77574-6_3
[10]  
HANCHETTE CL, 1992, CANCER, V70, P2861, DOI 10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO